Andres Ricaurte Fajardo, Neurology resident at Pontificia Universidad Javeriana, shared a post on LinkedIn:
“Proud to share our latest article in the Journal of Stroke and Cerebrovascular Diseases:
“Clinical characterization and predictors of poor outcome in patients with cerebral venous thrombosis: Experience from a Latin American cohort.”
This study, conducted at Hospital Universitario San Ignacio (Bogotá, Colombia), provides one of the largest Latin American datasets of cerebral venous thrombosis (CVT) to date — highlighting regional risk patterns, imaging features, and outcome predictors in a high-altitude, low- and middle-income setting.
Key take-home messages
- Headache remains the hallmark presentation — often mimicking migraine — emphasizing the need for high clinical suspicion even in isolated headache cases.
- Anemia emerged as an independent predictor of poor in-hospital outcome, underscoring the role of systemic factors in CVT prognosis.
- Venous infarction and subarachnoid hemorrhage were strong radiological predictors of poor functional recovery.
- The CVT Risk Score showed external validity in this Latin American cohort, supporting its use for bedside triage.
- These findings advocate for context-adapted risk stratification and management strategies tailored to LMIC environments.
- Active malignancy was present in 12% of cases — reinforcing the intersection between cancer and cerebral thrombosis, a relationship increasingly recognized in neuro-oncology and systemic disease.
Grateful to my amazing co-authors and mentors from Pontificia Universidad Javeriana for this collaborative effort toward advancing stroke research in Latin America.”
Title: Clinical characterization and predictors of poor outcome in patients with cerebral venous thrombosis: Experience from a Latin American cohort
Authors: Andres Felipe Cardenas-Cruz, Andres Ricaurte-Fajardo, Silvia Andrade, Carlos Alvarado-De la Hoz, Isabel Torres-Camacho, Elkin Garcia-Cifuentes, Maria Paula Ardila, Betty Arevalo, Carlos Beltran, Laura Monsalve, Luis Roa-Wandurraga, Juliana Coral-Casas
Read the Full Article.
More from Andres Ricaurte Fajardo on OncoDaily.